Study on the Selection of the Targets of Esophageal Carcinoma and Interventions of Ginsenosides Based on Network Pharmacology and Bioinformatics

Table 2

Clinical characteristics of ESCA patients.

Characteristic	n (%)
Age
<55 years	52 (28.42)
≥55 years	131 (71.58)
Gender
Female	27 (14.75)
Male	156 (85.25)
Survival status
Death	76 (41.53)
Survival	107 (58.47)
Alcohol consumption history
Yes	128 (69.95)
No	55 (30.05)
Radiation therapy
Yes	48 (26.23)
No	135 (73.77)
Pharmaceutical
Yes	42 (22.95)
No	141 (77.05)
T classification
T0	2 (1.09)
T1	32 (17.49)
T2	44 (24.04)
T3	100 (54.64)
T4	5 (2.73)
N classification
N0	79 (43.17)
N1	73 (39.89)
N2	21 (44.48)
N3	8 (4.37)
NX	2 (1.09)
Stage
I	14 (7.65)
II	92 (50.27)
III	65 (35.52)
IV	12 (6.56)
Histological grade
G1	19 (10.38)
G2	76 (41.53)
G3	48 (26.23)
GX	40 (21.86)
M classification
M0	148 (80.87)
M1	12 (6.56)
MX	23 (12.57)